4% Intrauterine Lidocaine Infusion for Pain Management in First Trimester Abortions
This study has been completed.
Sponsor:
Oregon Health and Science University
Information provided by:
Oregon Health and Science University
ClinicalTrials.gov Identifier:
NCT00121329
First received: July 13, 2005
Last updated: July 19, 2005
Last verified: July 2005
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Recent studies have investigated the use of local anesthetics (i.e. lidocaine, mepivacaine) to lessen the pain experienced with minor gynecologic procedures such as endometrial biopsy and office hysteroscopy. Local anesthetic injected into the uterine cavity has been demonstrated effective in some studies at decreasing patient pain associated with these intrauterine procedures at an anesthetic concentration of at least 2%. Based on this evidence, we hypothesized that an intrauterine lidocaine infusion may reduce patient pain during first trimester abortions.
Condition | Intervention |
---|---|
Pain |
Drug: Intrauterine lidocaine infusion 4% |
Study Type: | Interventional |
Study Design: | Allocation: Randomized Intervention Model: Single Group Assignment Masking: Double-Blind Primary Purpose: Treatment |
Official Title: | 4% Intrauterine Lidocaine Infusion for Pain Management in First Trimester Abortions |
Resource links provided by NLM:
Further study details as provided by Oregon Health and Science University:
Eligibility
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Age > 18 years old
- Good general health
- English speaking
- Confirmation of gestational age by ultrasound
- Body weight > 100 lbs.
- Pregnancy < 11 weeks
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00121329
Locations
United States, Oregon | |
Planned Parenthood of the Columbia Willamette | |
Portland, Oregon, United States, 97206 |
Sponsors and Collaborators
Oregon Health and Science University
Investigators
Principal Investigator: | Alison B Edelman, MD, MPH | Oregon Health and Science University |
More Information
No publications provided
Keywords provided by Oregon Health and Science University:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on October 16, 2012
No publications provided
ClinicalTrials.gov Identifier: | NCT00121329 History of Changes |
Other Study ID Numbers: | OHSU IRB 6876 |
Study First Received: | July 13, 2005 |
Last Updated: | July 19, 2005 |
Health Authority: | United States: Institutional Review Board |
Keywords provided by Oregon Health and Science University:
Pain with procedures |
Additional relevant MeSH terms:
Lidocaine Anesthetics, Local Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions |
Sensory System Agents Peripheral Nervous System Agents Central Nervous System Agents Therapeutic Uses Anti-Arrhythmia Agents Cardiovascular Agents |
ClinicalTrials.gov processed this record on October 16, 2012